Evidence map›Paper›PMID 24465401›Full record

ArticlePloS one2014

A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues.

Ramkumar Tiruvannamalai-Annamalai, David Randall Armant, Howard W T Matthew

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Skin substitutes: from conventional to 3D bioprinting.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  3. Article
  4. Tissue chips as headway model and incitement technology.Synthetic and systems biotechnology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ramkumar Tiruvannamalai-AnnamalaiDepartment of Biomedical Engineering, Wayne State University, Detroit, Michigan, United States of America.
David Randall ArmantDepartments of Obstetrics & Gynecology, Wayne State University, Detroit, Michigan, United States of America ; Program in Reproductive & Adult Endocrinology, National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
Howard W T MatthewDepartment of Biomedical Engineering, Wayne State University, Detroit, Michigan, United States of America ; Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, Michigan, United States of America.
Michigan United · USNational Institutes of Health · USWayne State University · US

Funding

Genetic Analysis of Human First Trimester Trophoblast in Ongoing PregnanciesR21HD071408 · NICHD · WAYNE STATE UNIVERSITY · PI ARMANT, DAVID RANDALL, DIAMOND, MICHAEL PETER · 2012 to 2013
$406k
NICHD NIH HHS HD067629NICHD NIH HHS R21 HD071408
6 · The paper itself

Abstract

The limited ability to vascularize and perfuse thick, cell-laden tissue constructs has hindered efforts to engineer complex tissues and organs, including liver, heart and kidney. The emerging field of modular tissue engineering aims to address this limitation by fabricating constructs from the bottom up, with the objective of recreating native tissue architecture and promoting extensive vascularization. In this paper, we report the elements of a simple yet efficient method for fabricating vascularized tissue constructs by fusing biodegradable microcapsules with tunable interior environments. Parenchymal cells of various types, (i.e. trophoblasts, vascular smooth muscle cells, hepatocytes) were suspended in glycosaminoglycan (GAG) solutions (4%/1.5% chondroitin sulfate/carboxymethyl cellulose, or 1.5 wt% hyaluronan) and encapsulated by forming chitosan-GAG polyelectrolyte complex membranes around droplets of the cell suspension. The interior capsule environment could be further tuned by blending collagen with or suspending microcarriers in the GAG solution These capsule modules were seeded externally with vascular endothelial cells (VEC), and subsequently fused into tissue constructs possessing VEC-lined, inter-capsule channels. The microcapsules supported high density growth achieving clinically significant cell densities. Fusion of the endothelialized, capsules generated three dimensional constructs with an embedded network of interconnected channels that enabled long-term perfusion culture of the construct. A prototype, engineered liver tissue, formed by fusion of hepatocyte-containing capsules exhibited urea synthesis rates and albumin synthesis rates comparable to standard collagen sandwich hepatocyte cultures. The capsule based, modular approach described here has the potential to allow rapid assembly of tissue constructs with clinically significant cell densities, uniform cell distribution, and endothelialized, perfusable channels.

Indexed as

AnimalsCell LineCells, CulturedEndothelial CellsGlycosaminoglycansHumansRatsTissue EngineeringTissue ScaffoldsGlycosaminoglycans

Identifiers

PMID24465401
PMCPMC3896358
OpenAlexW2080112652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.